Rare diseases
Investigational molecules
Locations
2000 Sierra Point Parkway Suite 1200, 94005-1806, United States
Vera Therapeutics Inc. focuses on clinical research in IgA nephropathy, also referred to as Berger disease, with studies centered on kidney inflammation and proteinuria in both adults and pediatric populations.
The sponsor’s trial portfolio includes work in patients with active renal disease and ongoing interest in clinical outcomes relevant to glomerular injury.
Vera Therapeutics Inc. runs clinical trials in conditions such as Glomerulonephritis membranous, Nephrotic syndrome, IgA nephropathy, Focal segmental glomerulosclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgium
PolandBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
